A lawsuit was filed for investors in shares of Envision Healthcare Corporation (NYSE: EVHC) in connection with the proposed takeover and NYSE: EVHC stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 07/25/2018 -- The Shareholders Foundation announces that an investor, who currently holds shares of Envision Healthcare Corporation (NYSE: EVHC), filed a lawsuit against the takeover of Envision Healthcare. by KKR.
Investors who purchased shares of Envision Healthcare Corporation (NYSE: EVHC) and currently hold any of those NYSE: EVHC shares have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The plaintiff alleges that the defendants breached their fiduciary duties owed to NYSE: EVHC stockholders by agreeing to sell Envision Healthcare Corporation cheaply via an unfair process.
On June 11, 2018, Envision Healthcare Corporation (NYSE: EVHC) announced it has entered into a agreement to be acquired by global investment firm KKR in an all-cash transaction for approximately $9.9 billion, including the assumption or repayment of debt. Under the terms of the agreement, KKR will acquire all of the outstanding shares of Envision's common stock for $46.00 per share in cash.
However, plaintiff claims that the proposed consideration NYSE: EVHC shareholders will receive is grossly inadequate and undervalues Envision Healthcare Corporation. Indee, at least one analyst has set the high target price for NYSE: EVHC shares at $51.00 per share and NYSE: EVHC shares traded in 2017 as high as $82.78 per share. Envision Healthcare Corporation reported that its annual Total Revenue rose from over $3.49 billion in 2016 to over $7.81 billion in 2017. In addition, the plaintiff alleges that the process is also unfair NYSE: EVHC stockholders
Those who are current investors in Envision Healthcare Corporation (NYSE: EVHC) shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels